[3H]-SR 27897B : A selective probe for autoradiographic labelling of CCK-A receptors in the brain

Journal of Receptor and Signal Transduction Research

Volumn 16, Issue 1-2, 1996, Pages 93-113

  Zajac, J M ^a   Gully, D ^b   Maffrand, J P ^b  

^a CNRS   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRITIUM; ANIMALIA;

1 [[2 [4 (2 CHLOROPHENYL)THIAZOL 2 YL]AMINOCARBONYL]INDOLYL]ACETIC ACID; BENZODIAZEPINE DERIVATIVE; CHOLECYSTOKININ A RECEPTOR; DEVAZEPIDE; LINTITRIPT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; CHOLECYSTOKININ RECEPTOR; HORMONE ANTAGONIST; INDOLEACETIC ACID DERIVATIVE; THIAZOLE DERIVATIVE;

ANIMAL TISSUE; AREA POSTREMA; ARTICLE; AUTORADIOGRAPHY; DRUG BINDING SITE; DRUG RECEPTOR BINDING; GENETIC HETEROGENEITY; ISOTOPE LABELING; NONHUMAN; OLIGONUCLEOTIDE PROBE; PANCREAS SECRETION; RAT; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; SOLITARY TRACT NUCLEUS; ANIMAL; BRAIN; KINETICS; METABOLISM; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; AUTORADIOGRAPHY; BRAIN; HORMONE ANTAGONISTS; INDOLEACETIC ACIDS; KINETICS; RATS; RATS, WISTAR; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, CHOLECYSTOKININ; THIAZOLES; TISSUE DISTRIBUTION;

EID: 0029658985     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899609039943     Document Type: Article

References (31)

1. Williams, J. ZA. Cholecystokinin:a hormone and a neurotransmitter. Biomed Res. 3, 107-121, 1982.
2. Vanderhaeghen, J.-J.; Signeau, J. C.; and Gepts, W. New peptide in vertebrate CMS reacting with antigastrin antibodies. Nature 257, 604-605, 1975.
3. Vanderhaeghen, J.-J.; Lotstra, F.; DeMey, J.; and Gilkes, C. Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat. Proc. Natl. Acad. Sci. USA 7, 1190-1194, 1980.
4. Dockray, G.J. Immunochemical evidence of cholecystokinin-like peptides in brain. Nature 264, 568-570, 1976.
5. Innis, R. B.; Correra, F. M. A.; Uhl, G. R.; Screider, B.; and Snyder, S.H. Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc. Natl. Acad. Sci. USA 76, 521-525, 1979.
6. Silver, A.F.; Flood, J.F.; Song, A.M.; and Morley, J.E. Evidence for a physiological role of CCK in the regulation of food intake in mice. Am. J. Physiol. 256, R646-652, 1989.
7. Reidelberger, R.D.; Kalogeris, T.J.; and Solomon, T.E. Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs., Am. J. Physiol. 256, R1148-1154, 1989.
8. Innis, R. B.; and Snyder, S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA 77, 6917-6921, 1980
9. Wank, S. A.; Harkins, R.; Jensen, R. T.; Shapira, H.; De Weerth, A.; and Slattery, T. Purification, molecular cloning and functional expression of the cholecystokinin receptors from rat pancreas. Proc. Natl. Acad. Sci. USA 89, 3125-3129, 1992.
10. Grider, J.R.; and Makhlouf, G.M. Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut. Gastroenterology 92, 175-180, 1987.
11. Liddle, R.A.; Green, G.M.; Conrad, C.K.; and Williams, J.A. Effect of a novel cholecystokinin receptor antagonist, MK329 on gall-bladder contraction and gastric emptying in humans. J. Clin. Invest. 84, 1220-1225, 1989.
12. Shaw, M.J.; Hadac, E.M.; and Miller, L.J. Preparation of enriched plasma membranes from bovine gall bladder muscularis for characterization of cholecystokinin receptors. J. Biol. Chem. 262, 14313-14318, 1987.
13. Hill, R.G.; Hughes, J.; and Pittaway, K.M. Antinociceptive action of cholecystokinin octapeptide (CCK8) and related peptides in rats and mice; Effects of naloxone and peptidase inhibitors. Neuropharmacol. 26, 289-300, 1987.
14. Hewson, G.; Leighton, G.E.; Hill, R.G.; and Hughes, J. The cholecystokinin receptor antagonist L-374,718 increases food intake in the rat by attenuating of the action of endogenous cholecystokinin. Br. J. Pharmacol. 93, 79-84, 1988.
15. Faris, P.L.; Komisaruk, B.R.; Watkins, L.R.; and Mayer, D.J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 219, 310-312, 1983.
16. Wieterlak, E.P.; Maier, S.F.; and Watkins, L.R. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science 256, 830-833, 1992.
17. Moran, T.H.; Robinson, P.; Goldrich, M.S.; and McHugh, P. Two brain cholecystokinin receptors: Implications for behavioural actions. Brain Res. 362, 175-179, 1986.
18. Chang, R.S.L.; Lotti, V.J.; Chen, T.B.; and Keegan, M.E. Tifluadom; a κ-opiate agonist, acts as a peripheral cholecystokinin receptor antagonist. Neurosci. Lett. 72, 211-214, 1986.
19. Chang, R. S. L. and Lotti, V. J. Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA 83, 4923-4926, 1986.
20. Hill, D.R.; Campbell, N.J.; Show, T.M.; and Woodruff, G.N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neuroscience 7, 2967-2976, 1987.
21. Hill, D.R.; Shaw, T.M.; Graham, W.; and Woodruff, G.N. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 1251Bolton Hunter CCK8 and 3H-MK-329. J. Neuroscience. 10, 1070-1081, 1990.
22. Gully, D.; Fréhel, D.; Marcy, C.; Spinazzé, A.; Lespy, L.; Neliat, G.; Maffrand, J.-P.; and Le Fur, G. Peripheral biological activity of SR27897B: a new potent non-peptide anatgonist of CCKA receptors. Eur. J. Pharmacol. 232, 13-19, 1993.
23. Poncelet, M.; Arnone, M.; Heaulme, M.; Gonalons, N.; Gueudet, C.; Santucci, V.; Thurneyssen, O.; Keane, P.; Gully, D.; Le Fur, G.; and Subrié, P. Neurobehavioural effects of SR27897B, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 102-107, 1993.
24. Kuhar, M.J.; and Unnerstall, J. R. Quantitative receptor mapping by autoradiography : some current technical problems. Trends Neurosci. 49-53, 1985.
25. Paxinos, G.; and Watson, C. The rat brain in stereotaxic coordinates. Academic Press, New-York, 1982.
26. Denauvit-Saubié, M.; Hurle, M.; Morin-Satin, P.; Foutz, A.S.; and Champagnat, J. The effects of cholecystokinin-8 in the nucleus tractus solitarius. Ann. NY Acad. Sci. 448, 375-384, 1985.
27. Morin, M.P.; DeMarchi, P.; Champagnat, J.; Vanderhaeghen, J. J.; Rossier, J.; and Denauvit-Saubié, M. Inhibitory effects of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius. Brain Res. 265, 333-338, 1983.
28. Miaskiewicz, S.L.; Stricker, E.M.; and Verbalis, J.G. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distension in humans. J. Clin. Endocr. Metab. 68, 837-843, 1989.
29. Parrott, R.F.; and Forsling, M.L The CCKA receptor antagonist devazepide inhibits the effect of apomorphine on vasopressin release in pigs. Gen. Pharmac. 25, 1337-1340, 1994.
30. Wislocki, G. B.; and Putnam, T. J. Note on the anatomy of the area postrema. Anat. Rec. 19, 281-287, 1920.
31. Worms, P.; Gueudet, C.; and Biziére, K. Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice : pharmacological analysis of a simple screening model. Life Sci. 39, 2199-2208, 1986.